Pregled bibliografske jedinice broj: 451430
Obesity in Type 2 Diabetes : Prevalence, Treatment Trends and Dilemmas
Obesity in Type 2 Diabetes : Prevalence, Treatment Trends and Dilemmas // Collegium antropologicum, 35 (2011), 3; 829-834 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 451430 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Obesity in Type 2 Diabetes : Prevalence, Treatment Trends and Dilemmas
Autori
Poljičanin, Tamara ; Pavlić-Renar, Ivana ; Metelko, Željko
Izvornik
Collegium antropologicum (0350-6134) 35
(2011), 3;
829-834
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
diabetes mellitus ; epidemiology ; obesity ; overweight ; prevalence ; weight gain
Sažetak
This retrospective observational study investigated the prevalence of obesity in persons with type 2 diabetes, trends in obesity resulting from the duration and treatment of diabetes, and treatment-related changes in HbA1c and body mass index (BMI). Data on 1773 type 2 diabetics (802 men and 971 women) were obtained from the CroDiabNET registry. Follow-up included the analysis of patients’ age, disease duration, diabetes treatment, BMI and HbA1c values. A significantly higher rate of overweight and obesity was found in persons with type 2 diabetes as compared to the general population. A significant decrease in BMI was observed in the groups treated by diet, and in those treated by oral hypoglycaemic agents (p<0.05), regardless of their pharmacotherapeutic group, in contrast to a significant increase in BMI observed in the groups treated with insulin (alone or in combination with oral hypoglycaemic agents) (p<0.05). Persons with type 2 diabetes lost weight only during the first years of the disease, while with diabetes duration and insulin treatment they regained weight. A significant increase in HbA1c was observed in the groups treated with sulfonylureas (p<0.05), whereas all other groups revealed either a significant decrease (p<0.05) or no change in HbA1c. Our findings suggest the necessity of an integrated approach to managing type 2 diabetic patients that would simultaneously address both diabetes and obesity. Good glycaemic control is imperative and diabetes treatment should not be postponed. Because of a possible concomitant weight gain, aggressive weight control measures should be applied concurrently in order to achieve maximum treatment benefit.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-0450961-0960 - Ispitivanje učestalost kroničnih komplikacija šećerne bolesti u R Hrvatskoj (Metelko, Željko, MZOS ) ( CroRIS)
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE